Literature DB >> 15726318

[Five-year results following autogenous osteochondral transplantation to the femoral head].

Marcus Rittmeister1, K Hochmuth, S Kriener, J Richolt.   

Abstract

The rationale for autogenous osteochondral grafting into necrotic areas of the femoral head is to provide hyaline cartilage for areas of main articular contact pressure. The aim of this study was to present our results of autogenous osteochondral grafting to the femoral head in the treatment of avascular necrosis. The mean follow-up of the five patients was 57 months following autogenous osteochondral grafting to the femoral head using DBCS (diamond bone-cutting system). The number of transplanted cylinders varied between one and three, and the diameter of the cylindrical transplants between 9 and 13 mm. Results were unsatisfactory in four of five hips and these underwent total hip replacement a mean of 49 months following DBCS of the hip. In our hands, osteochondral grafting to the femoral head using DBCS had proven technically possible in restoring the articular surface of the femoral head; however, this operation was associated with unsatisfactory results in four of five cases.

Entities:  

Mesh:

Year:  2005        PMID: 15726318     DOI: 10.1007/s00132-005-0776-y

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  21 in total

1.  Topographic matching of selected donor and recipient sites for osteochondral autografting of the articular surface of the femoral condyles.

Authors:  R L Bartz; E Kamaric; P C Noble; D Lintner; J Bocell
Journal:  Am J Sports Med       Date:  2001 Mar-Apr       Impact factor: 6.202

2.  Treatment of the necrotic head of the femur in adults.

Authors:  D B PHEMISTER
Journal:  J Bone Joint Surg Am       Date:  1949-01       Impact factor: 5.284

3.  Idiopathic bone necrosis of the femoral head. Early diagnosis and treatment.

Authors:  R P Ficat
Journal:  J Bone Joint Surg Br       Date:  1985-01

4.  Surgery for aseptic necrosis of the femoral head.

Authors:  D S Springfield; W J Enneking
Journal:  Clin Orthop Relat Res       Date:  1978 Jan-Feb       Impact factor: 4.176

5.  [Experiences with homoplastic osteocartilaginous transplantation of the femur head cap].

Authors:  F Stryhal; Z Matejovsky
Journal:  Z Orthop Ihre Grenzgeb       Date:  1972-12

6.  [Possibilities and experiences with cartilage transplantation].

Authors:  H Wagner
Journal:  Z Orthop Ihre Grenzgeb       Date:  1972-12

7.  [The principle of autogeneic rib perichondrial transplantation in the treatment of deep articular cartilage defects].

Authors:  J Bruns; P Behrens; M Silbermann
Journal:  Z Orthop Ihre Grenzgeb       Date:  1997 Mar-Apr

Review 8.  [Autologous osteochondral transplantation on various joints].

Authors:  A B Imhoff; G M Ottl; A Burkart; S Traub
Journal:  Orthopade       Date:  1999-01       Impact factor: 1.087

9.  [Experiences with arthroscopic therapy of chondral and osteochondral defects of the knee joint with OATS (Osteochondral Autograft Transfer System)].

Authors:  W Attmanspacher; V Dittrich; H W Stedtfeld
Journal:  Zentralbl Chir       Date:  2000       Impact factor: 0.942

10.  Fresh autogenous grafts and osteochondral allografts for the treatment of segmental collapse in osteonecrosis of the hip.

Authors:  M H Meyers; R E Jones; R W Bucholz; D R Wenger
Journal:  Clin Orthop Relat Res       Date:  1983-04       Impact factor: 4.176

View more
  12 in total

1.  Surgical technique: Second-generation bone marrow stimulation via surgical dislocation to treat hip cartilage lesions.

Authors:  Michael Leunig; Lisa M Tibor; Florian D Naal; Reinhold Ganz; Matthias R Steinwachs
Journal:  Clin Orthop Relat Res       Date:  2012-12       Impact factor: 4.176

2.  Comment on Gagala et al.: Clinical and radiological outcomes of avascular necrosis of the femoral head using autologous osteochondral transfer (mosaicplasty). Preliminary report.

Authors:  Vishal Kumar; Siddhartha Sharma; Sameer Aggarwal; Vijay G Goni
Journal:  Int Orthop       Date:  2013-06-22       Impact factor: 3.075

Review 3.  [Cartilage regeneration surgery on the hip : What is feasible?]

Authors:  Stefan Landgraeber; Marcus Jäger; Stefan Fickert
Journal:  Orthopade       Date:  2017-11       Impact factor: 1.087

4.  Operative treatment of chondral defects in the hip joint: a systematic review.

Authors:  Mark A Jordan; Geoffrey S Van Thiel; Jaskarndip Chahal; Shane J Nho
Journal:  Curr Rev Musculoskelet Med       Date:  2012-09

5.  Steroid-induced femoral head osteonecrosis in immune thrombocytopenia treatment with osteochondral autograft transplantation.

Authors:  Vasileios Ch Fotopoulos; George Mouzopoulos; Themistoklis Floros; Matthaios Tzurbakis
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-08-31       Impact factor: 4.342

6.  [Autologous osteochondral transplants].

Authors:  R Schnettler; U Horas; C Meyer
Journal:  Orthopade       Date:  2008-08       Impact factor: 1.087

Review 7.  Stem cell- and growth factor-based regenerative therapies for avascular necrosis of the femoral head.

Authors:  Lars Rackwitz; Lars Eden; Stephan Reppenhagen; Johannes C Reichert; Franz Jakob; Heike Walles; Oliver Pullig; Rocky S Tuan; Maximilian Rudert; Ulrich Nöth
Journal:  Stem Cell Res Ther       Date:  2012-02-22       Impact factor: 6.832

8.  Response to comment on Gagala et al.: Clinical and radiological outcomes of treatment of avascular necrosis of the femoral head using autologous osteochondral transfer (mosaicplasty). Preliminary report.

Authors:  Jacek Gagala; Marta Tarczyńska; Krzysztof Gawęda
Journal:  Int Orthop       Date:  2013-08       Impact factor: 3.075

9.  Hip Microfracture: Indications, Technique, and Outcomes.

Authors:  Kevin C McGill; Charles A Bush-Joseph; Shane J Nho
Journal:  Cartilage       Date:  2010-04       Impact factor: 4.634

10.  Clinical and radiological outcomes of treatment of avascular necrosis of the femoral head using autologous osteochondral transfer (mosaicplasty): preliminary report.

Authors:  Jacek Gagala; Marta Tarczyńska; Krzysztof Gawęda
Journal:  Int Orthop       Date:  2013-05-01       Impact factor: 3.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.